Rigel Pharmaceuticals | Resultado Líquido





Resultado Líquido Alterar Data
Agenus USD -25.27M 20.59M 2025-03
Amgen USD 1.33B 1.88B 2025-12
Anika Therapeutics USD -4.87M 16.99M 2025-03
Arrowhead Research USD 30.81M 54.56M 2025-12
AstraZeneca USD 2.33B 207M 2025-12
BioMarin Pharmaceutical USD -30.74M 271.28M 2025-09
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Celldex Therapeutics USD -67.04M 10.44M 2025-09
Daiichi Sankyo JPY 86.63B 41.32B 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Halozyme Therapeutics USD 175.22M 10.06M 2025-09
Heron Therapeutics USD -4.85M 4.39M 2024-09
Ionis Pharmaceuticals USD -128.61M 252.16M 2025-09
Karyopharm Therapeutics USD -30.78M 1.29M 2024-12
Ligand Pharmaceuticals USD 117.27M 112.43M 2025-09
MacroGenics USD 16.82M 53.07M 2025-09
Neurocrine Biosciences USD 209.5M 102M 2025-09
Pfizer USD -1.65B 5.19B 2025-12
Regeneron Pharmaceuticals USD 844.6M 615.4M 2025-12
Rigel Pharmaceuticals USD 12.42M 13.45M 2024-09
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Ultragenyx Pharmaceutical USD -180.41M 65.46M 2025-09
Veracyte USD 19.14M 20.12M 2025-09


Rigel Pharmaceuticals Resultado Líquido - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.